Depressing News Pt 2

I just received this email 2 minutes ago from GSK Corporate Communications, an addendum to today's press release- well what can I say it gets more interesting...

"GSK rejects any suggestion that we deliberately withheld data on paroxetine from NICE. GSK provided both published and unpublished data as part of the development of the NICE guidelines regarding the licensed use of paroxetine in adults with depression, anxiety disorder, post traumatic stress disorder and obsessive compulsive disorder. In addition GSK responded to a request for data on the use of paroxetine in children. The company provided a list of the studies that had either been completed or were underway however this was an unlicensed indication (that is to say the product was not approved for use in this patient population) and was subject to an ongoing regulatory review by the MHRA. It was therefore not appropriate to provide these data to NICE ahead of the MHRA's conclusions."